Your browser doesn't support javascript.
loading
Temporal Alterations in CD8+ T Cells During the Progression From Stage 1 to Stage 3 Type 1 Diabetes.
Schroderus, Anna-Mari; Pitkänen, Viola; Ekman, Ilse; Stevens, Daniella; Rytkönen-Nissinen, Marja; Rintamäki, Reeta; Pihlajamäki, Jussi; Knip, Mikael; Veijola, Riitta; Toppari, Jorma; Ilonen, Jorma; Lempainen, Johanna; Kinnunen, Tuure.
Afiliación
  • Schroderus AM; Department of Clinical Microbiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
  • Pitkänen V; Department of Clinical Microbiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
  • Ekman I; Department of Clinical Microbiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
  • Stevens D; Department of Clinical Microbiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
  • Rytkönen-Nissinen M; Department of Clinical Microbiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
  • Rintamäki R; Department of Medicine, Endocrinology and Clinical Nutrition, Kuopio University Hospital, Kuopio, Finland.
  • Pihlajamäki J; Department of Medicine, Endocrinology and Clinical Nutrition, Kuopio University Hospital, Kuopio, Finland.
  • Knip M; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
  • Veijola R; Tampere Center for Child Health Research, Tampere University Hospital, Tampere, Finland.
  • Toppari J; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Ilonen J; Research Unit of Clinical Medicine, Department of Pediatrics, Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Lempainen J; Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland.
  • Kinnunen T; Research Centre for Integrative Physiology and Pharmacology, InFLAMES Research Flagship, Institute of Biomedicine, University of Turku, Turku, Finland.
Diabetes ; 73(10): 1705-1715, 2024 Oct 01.
Article en En | MEDLINE | ID: mdl-38967999
ABSTRACT
CD8+ T cells are perceived to play a major role in the pathogenesis of type 1 diabetes (T1D). In this study, we characterized the function and phenotype of circulating CD8+ memory T cells in samples from individuals at different stages of T1D progression using flow cytometry and single-cell multiomics. We observed two distinct CD8+ T-cell signatures during progression of T1D within the highly differentiated CD27-CD8+ memory T-cell subset. A proinflammatory signature, with an increased frequency of IFN-γ+TNF-α+ CD27-CD8+ memory T cells, was observed in children with newly diagnosed T1D (stage 3) and correlated with the level of dysglycemia at diagnosis. In contrast, a coinhibitory signature, with an increased frequency of KLRG1+TIGIT+ CD27-CD8+ memory T cells, was observed in islet autoantibody-positive children who later progressed to T1D (stage 1). No alterations within CD27-CD8+ memory T cells were observed in adults with established T1D or in children during the initial seroconversion to islet autoantibody positivity. Single-cell multiomics analyses suggested that CD27-CD8+ T cells expressing the IFNG+TNF+ proinflammatory signature may be distinct from those expressing the KLRG1+TIGIT+ coinhibitory signature at the single-cell level. Collectively, our findings suggest that distinct blood CD8+ T-cell signatures could be employed as potential biomarkers of T1D progression.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Progresión de la Enfermedad / Linfocitos T CD8-positivos / Diabetes Mellitus Tipo 1 Idioma: En Revista: Diabetes Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Progresión de la Enfermedad / Linfocitos T CD8-positivos / Diabetes Mellitus Tipo 1 Idioma: En Revista: Diabetes Año: 2024 Tipo del documento: Article